Action Potential Venture Capital
GlaxoSmithKline today announced the launch of Action Potential Venture Capital (APVC) Limited, a new $50 million strategic venture capital fund that will invest in companies that pioneer bioelectronic medicines and technologies. The fund’s first investment will be in SetPoint Medical, a California company considered a trailblazer in creating implantable devices to treat inflammatory diseases. The fund complements the work of GSK’s Bioelectronics R&D unit, which was established in 2012 after a two-year effort to seek out and engage the most promising researchers in thi...
read more
GlaxoSmithKline today announced the launch of Action Potential Venture Capital (APVC) Limited, a new $50 million strategic venture capital fund that will invest in companies that pioneer bioelectronic medicines and technologies. The fund’s first investment will be in SetPoint Medical, a California company considered a trailblazer in creating implantable devices to treat inflammatory diseases. The fund complements the work of GSK’s Bioelectronics R&D unit, which was established in 2012 after a two-year effort to seek out and engage the most promising researchers in this emerging area of science. The name of the fund comes from electrical signals called action potentials that pass along the nerves in the body. Irregular or altered patterns of these impulses may occur in association with a broad range of diseases. GSK believes that miniaturised devices, or bioelectronic medicines, can be designed to read these patterns. The devices could be designed to interface between the peripheral nervous system and specific organs to read, change or generate electronic impulses that help treat disorders as diverse as inflammatory bowel disease or rheumatoid arthritis; respiratory diseases such as asthma and COPD and metabolic diseases including Type 2 diabetes. The field of bioelectronic medicines is in its very early stages. GSK’s ambition, through collaboration with scientists globally, is to have the first medicine that speaks the electrical language of our body ready for approval by the end of this decade.“We want to help create the medicines of the future and be the catalyst for this work,” said Moncef Slaoui, chairman of R&D and architect of GSK’s early stage investment strategy. “GSK can play the integrating role that is needed to drive this new type of medical treatment all the way from the bench to the patient and this fund is a key part of our efforts.” Action Potential Venture Capital intends to build a portfolio of five to seven companies over the next five years. The fund will focus investments in three areas: - New start-up companies that aim to pursue the vision of bioelectronic medicines - Existing companies with technologies that are interacting with the peripheral nervous system through first-generation devices that can stimulate or block electrical impulses - Companies advancing technology platforms that will underpin these treatment modalities Action Potential Venture Capital will be based in Cambridge, Massachusetts and managed by a small, dedicated team. The fund has named Imran Eba as its first partner. Imran will move from GSK’s Worldwide Business Development organisation and work closely with the Bioelectronics R&D unit.
show less
Website | actionpotentialvc.com | |
Industry | Venture Capital & Private Equity | |
Location | Palo Alto, California, United States |
HQ | One Broadway 4th Floor |
Website | ||
Industry | Venture Capital & Private Equity | |
Employees | 4 | |
HQ | One Broadway 4th Floor |
Top Competitor for Action Potential Venture Capital
Action Potential Venture Capital Questions
Where are action potential venture capital's headquarters?
action potential venture capital's headquarters are in One Broadway 4th Floor
What is action potential venture capital's official website?
action potential venture capital's website is actionpotentialvc.com
How many employees are working in action potential venture capital right now?
action potential venture capital has
4 employees.
View the Email and Phone Numbers for all 4 working at action potential venture capital.
What is action potential venture capital's industry?
action potential venture capital's industry is
Venture Capital & Private Equity
Who are action potential venture capital's top competitors?
action potential venture capital's top competitors are
Conscience Vc
,
Virgin
,
Blenheim Chalcot
,
Sequoia Capital China
,
Hult Prize Foundation
,
Fastercapital
,
Tpg Global
,
Verizon Ventures
,
The Heritage Group
,
Antler
What are action potential venture capital's categories?
action potential venture capital's categories are Finance, Venture Capital
What is action potential venture capital's location?
action potential venture capital's location is
Palo Alto, California, United States
What is action potential venture capital's current status?
action potential venture capital's current status is operating
Top Action Potential Venture Capital Employees
Investor
jcueva@stanford.edu
+1650-285-4395
Venture Lead
pmenzies@ucsd.edu
+1585-520-1329
Investor
jcueva@stanford.edu
+1650-285-4395
Venture Lead
pmenzies@ucsd.edu
+1585-520-1329
Summer Associate Intern
legbosiuba@uga.edu